Artelo Biosciences’ (ARTL) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital reiterated their buy rating on shares of Artelo Biosciences (NASDAQ:ARTL – Free Report) in a report issued on Wednesday,Benzinga reports. D. Boral Capital currently has a $6.00 price target on the stock. ARTL has been the topic of a number of other reports. HC Wainwright reaffirmed a “buy” rating and issued a […]
D. Boral Capital reiterated their buy rating on shares of Artelo Biosciences (NASDAQ:ARTL – Free Report) in a report issued on Wednesday,Benzinga reports. D. Boral Capital currently has a $6.00 price target on the stock. ARTL has been the topic of a number of other reports. HC Wainwright reaffirmed a “buy” rating and issued a […]
